Treatment of stage IV neuroblastoma with allogeneic hematopoietic stem cell transplantation in children

Chinese Journal of Contemporary Pediatrics

Volumn 10, Issue 4, 2008, Pages 464-466

  Lu, Quan Yi ^a   Wang, Zhao ^a   Li, Pu ^a   Niu, Xiao Qing ^a   Zhang, Peng ^a   Zhao, Jiang Ning ^a  

^a ZHONGSHAN HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

Allogeneic; Child; Hematopoietic stem cell transplantation; Neuroblastoma

Indexed keywords

FLUDARABINE; HLA ANTIGEN; MELPHALAN;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER STAGING; CASE REPORT; CHIMERA; CLINICAL EFFECTIVENESS; FOLLOW UP; HAPLOIDY; HEMATOPOIETIC STEM CELL; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOTHER; NEUROBLASTOMA; NEUTROPHIL COUNT; PERIPHERAL BLOOD STEM CELL; POLYMERASE CHAIN REACTION; SCHOOL CHILD; SHORT TANDEM REPEAT; SURVIVAL TIME; THROMBOCYTE COUNT;

CHILD; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; NEOPLASM STAGING; NEUROBLASTOMA; TRANSPLANTATION, HOMOLOGOUS;

EID: 50249125261     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Chinese source.
2. Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cisretinoicacid. Children's Cancer Group [J]. N Engl J Med, 1999, 341(16): 1165-1173.
3. Chinese source.
4. George RE, Li S, Medeiros-Nancarrow C, Neuberg D, Marcus K, Shamberger RC, et al. High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: long-term survival update [J]. J Clin Oncol, 2006, 24 (18): 2891-2896.
5. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation [J]. N Engl J Med, 2000, 343 (11): 750-758.
6. Inoue M, Nakano T, Yoneda A, Nishikawa M, Nakayama M, Yumura-Yagi K, et al. Graft-versus-tumor effect in a patient with advanced neuroblastoma who received HLA haplo-identical bone marrow transplantation [J]. Bone Marrow Transplant, 2003, 32 (1): 103-106.
7. Matthay KK, Seeger RC, Reynolds CP, Stram DO, O'Leary MC, Harris RE, et al. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Children's Cancer Group [J]. J Clin Oncol, 1994, 12(11): 2382-2389.
8. Chinese source.
9. Pedrazzoli P, Da Prada GA, Giorgiani G, Schiavo R, Zambelli A, Giraldi E, et al. Allogeneic blood stem cell transplantation after a reduced-intensity, praparative regimen: a pilot study in patients with refractory malignancies [J]. Cancer, 2002, 94 (9): 2409-2415.
10. Kim EK, Kang HJ, Park JA, Choi HS, Shin HY, Ahn HS. Retrospective analysis of peripheral blood stem cell transplantation for the treatment of high-risk neuroblastoma [J]. J Korean Med Sci, 2007, 22(Suppl): S66-72.
11. Kasow KA, Sims-Poston L, Eldridge P, Hale GA. CD34 (+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients[J]. Biol Blood Marrow Transplant, 2007, 13 (5): 608-614.
12. Chinese source.
13. Chinese source.
14. Chinese source.